These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 21969301)

  • 1. Egr1 expression is induced following glatiramer acetate immunotherapy in rodent models of glaucoma and Alzheimer's disease.
    Bakalash S; Pham M; Koronyo Y; Salumbides BC; Kramerov A; Seidenberg H; Berel D; Black KL; Koronyo-Hamaoui M
    Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):9033-46. PubMed ID: 21969301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noggin and BMP4 co-modulate adult hippocampal neurogenesis in the APP(swe)/PS1(DeltaE9) transgenic mouse model of Alzheimer's disease.
    Tang J; Song M; Wang Y; Fan X; Xu H; Bai Y
    Biochem Biophys Res Commun; 2009 Jul; 385(3):341-5. PubMed ID: 19463786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal gene profiling in a hereditary rodent model of elevated intraocular pressure.
    Naskar R; Thanos S
    Mol Vis; 2006 Oct; 12():1199-210. PubMed ID: 17102796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leptin induces proliferation of neuronal progenitors and neuroprotection in a mouse model of Alzheimer's disease.
    Pérez-González R; Antequera D; Vargas T; Spuch C; Bolós M; Carro E
    J Alzheimers Dis; 2011; 24 Suppl 2():17-25. PubMed ID: 21335656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microarray analysis of retinal gene expression in the DBA/2J model of glaucoma.
    Steele MR; Inman DM; Calkins DJ; Horner PJ; Vetter ML
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):977-85. PubMed ID: 16505032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in gene expression in experimental glaucoma and optic nerve transection: the equilibrium between protective and detrimental mechanisms.
    Yang Z; Quigley HA; Pease ME; Yang Y; Qian J; Valenta D; Zack DJ
    Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5539-48. PubMed ID: 18055803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental glaucoma and optic nerve transection induce simultaneous upregulation of proapoptotic and prosurvival genes.
    Levkovitch-Verbin H; Dardik R; Vander S; Nisgav Y; Kalev-Landoy M; Melamed S
    Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2491-7. PubMed ID: 16723461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The alpha7 nicotinic receptor agonist 4OH-GTS-21 protects axotomized septohippocampal cholinergic neurons in wild type but not amyloid-overexpressing transgenic mice.
    Ren K; King MA; Liu J; Siemann J; Altman M; Meyers C; Hughes JA; Meyer EM
    Neuroscience; 2007 Aug; 148(1):230-7. PubMed ID: 17640819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoreactive antibodies and loss of retinal ganglion cells in rats induced by immunization with ocular antigens.
    Laspas P; Gramlich OW; Müller HD; Cuny CS; Gottschling PF; Pfeiffer N; Dick HB; Joachim SC; Grus FH
    Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):8835-48. PubMed ID: 22003114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide expression profiling of the retinoschisin-deficient retina in early postnatal mouse development.
    Gehrig A; Langmann T; Horling F; Janssen A; Bonin M; Walter M; Poths S; Weber BH
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):891-900. PubMed ID: 17251492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive cognitive impairment and anxiety induction in the absence of plaque deposition in C57BL/6 inbred mice expressing transgenic amyloid precursor protein.
    Lee KW; Lee SH; Kim H; Song JS; Yang SD; Paik SG; Han PL
    J Neurosci Res; 2004 May; 76(4):572-80. PubMed ID: 15114629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression changes in the retina following optic nerve transection.
    Piri N; Kwong JM; Song M; Elashoff D; Caprioli J
    Mol Vis; 2006 Dec; 12():1660-73. PubMed ID: 17200666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
    Aharoni R; Vainshtein A; Stock A; Eilam R; From R; Shinder V; Arnon R
    J Autoimmun; 2011 Nov; 37(3):228-41. PubMed ID: 21752599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expressional changes of Th1 and Th2 cells in retina of a rat glaucoma model vaccinated by Cop-1].
    Cheng LN; Qian SH; Sun XH; Tian J; Tang YT; Wang Y
    Zhonghua Yi Xue Za Zhi; 2011 Oct; 91(39):2789-92. PubMed ID: 22322063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway.
    Jaffar S; Counts SE; Ma SY; Dadko E; Gordon MN; Morgan D; Mufson EJ
    Exp Neurol; 2001 Aug; 170(2):227-43. PubMed ID: 11476589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1.
    Butovsky O; Koronyo-Hamaoui M; Kunis G; Ophir E; Landa G; Cohen H; Schwartz M
    Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11784-9. PubMed ID: 16864778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Species-specific immune response to immunization with human versus rodent A beta peptide.
    Seabrook TJ; Bloom JK; Iglesias M; Spooner ET; Walsh DM; Lemere CA
    Neurobiol Aging; 2004 Oct; 25(9):1141-51. PubMed ID: 15312960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of ageing on neurogenesis and oxidative stress in the APP(swe)/PS1(deltaE9) mouse model of Alzheimer's disease.
    Hamilton A; Holscher C
    Brain Res; 2012 Apr; 1449():83-93. PubMed ID: 22418058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glatiramer acetate positively influences spinal motoneuron survival and synaptic plasticity after ventral root avulsion.
    Scorisa JM; Zanon RG; Freria CM; de Oliveira AL
    Neurosci Lett; 2009 Feb; 451(1):34-9. PubMed ID: 19103252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glatiramer acetate could be a potential therapeutic agent for Parkinson's disease through its neuroprotective and anti-inflammatory effects.
    Tsai SJ
    Med Hypotheses; 2007; 69(6):1219-21. PubMed ID: 17548170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.